<PAGE>
SCHEDULE 14A
(RULE 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
PROXY STATEMENT PURSUANT TO SECTION 14(a) OF THE SECURITIES
EXCHANGE ACT OF 1934
Filed by the Registrant [X]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
[_] Preliminary Proxy Statement
[_] Confidential, for Use of the Commission Only (as permitted
by Rule 14a-6(e)(2))
[_] Definitive Proxy Statement
[X] Definitive Additional Materials
[_] Soliciting Material Pursuant to Section 240.14a-11(c) or
Section 240.14a-12
DRKOOP.COM, INC.
-----------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
-----------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
and 0-11.
(1) Title of each class of securities to which transaction applies:
----------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
----------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
----------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
----------------------------------------------------------
(5) Total fee paid:
----------------------------------------------------------
[_] Fee paid previously with preliminary materials.
[_] Check box if any part of the fee is offset as provided by Exchange Act Rule
0-11(a)(2) and identify the filing for which the offsetting fee was paid
previously. Identify the previous filing by registration statement number,
or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
----------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
----------------------------------------------------------
(3) Filing Party:
----------------------------------------------------------
(4) Date Filed:
----------------------------------------------------------
<PAGE>
[LETTERHEAD OF DRKOOP.COM]
7000 N. Mopac, Suite 400
Austin, Texas 78731
NOTICE TO STOCKHOLDERS OF DRKOOP.COM, INC.
December 6, 2000
Dear Stockholders:
After we mailed our proxy statement to you with respect to our annual
meeting of stockholders to be held on December 13, 2000, we received a letter
from the Nasdaq Stock Market, Inc. concerning the trading price of our common
stock. The letter stated that our common stock has not met Nasdaq's $1.00
minimum bid price closing requirement for thirty consecutive trading days and
that if we are unable to demonstrate compliance with this requirement for ten
consecutive trading days during the ninety calendar days preceding February 22,
2001, our common stock would be delisted at the close of business on February
26, 2001. Our Board of Directors has determined that we will call a special
meeting of our stockholders to vote on a reverse stock split if such a meeting
is necessary to increase our stock price above Nasdaq's $1.00 minimum bid price
requirement. The ratio of such a reverse stock split will not be determined
until on or before the date a proxy statement relating to this special meeting
is mailed to our stockholders. If we are unable to hold the special meeting and
set the record date for the reverse stock split sufficiently in advance of
February 22, 2001 to demonstrate compliance with Nasdaq's minimum bid
requirements, we may request a hearing by the Nasdaq Listing Qualifications
Panel which will stay the delisting of our common stock pending the Panel's
decision. There can be no assurance that we will be able to demonstrate
compliance with Nasdaq's minimum bid price closing requirement by February 22,
2001 and that such a hearing will not be necessary.
We look forward to your attendance either in person or by proxy at our
December 13, 2000 annual meeting of stockholders.
Very truly yours,
/s/ Richard M. Rosenblatt
Richard M. Rosenblatt
Chief Executive Officer
